The initial PSP cohort (N = 481) with genome-wide genotyping and tau pathology LTs, were tested for LT/SNP associations using linear regression under an additive model and age and sex as covariates. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.